Author

V. Vavinskaya

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

C. O'Connor· 1 shared C. Tsui· 1 shared C.-Y. Chung· 1 shared D. Tuveson· 1 shared D. Wang· 1 shared E. Hasnis· 1 shared G. Erikson· 1 shared G. Wahl· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. O'Connor

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 6, 2020

Regulation of HDAC2-PDX1 by RNF125 defines pancreatic cancer development

E. Hasnis, H. Kim, S. Verma…·Z. A. Ronai

This study identifies RNF125's role in regulating HDAC2 and PDX1 to influence pancreatic cancer development and patient outcomes.

DOI 10.1101/2020.01.06.896555

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 19, 2019

Tuft cells restrain pancreatic tumorigenesis through paracrine eicosanoid signaling

K. E. DelGiorno, C.-Y. Chung, H. C. Maurer…·G. Wahl

This study shows that tuft cells suppress pancreatic tumorigenesis by producing anti-inflammatory prostaglandin D2, which inhibits stromal activation, and identifies their protective role in early disease progression.

DOI 10.1101/2019.12.19.882985

𝕏 PostBluesky